TIRZEPATIDE
The new class of drugs being studied to treat obesity is Tirzepatide. Tirzepatide activates the body's GIP (glucose dependent insulinotropic polypeptide), and GLP-1 receptors. It is given once a week. Semaglutide, a GLP-1 activator and FDA approved weight loss drug, is a relatively new medication. Weight loss medication is not...









